Variable levels of upregulated expression were also observed in studies on other cancer types including gastric, lung or hepatocellular cancer, where stratification into groups with low and high ANRIL expression revealed correlations with metastasis or survival [21,23,37]. The gene discussed is CDKN2B-AS1; the disease is hepatocellular carcinoma.